According to the principles for the appointment of the Nomination Committee in Isofol Medical AB adopted at the annual general meeting held on 3 May 2018, the Nomination Committee for the annual general meeting 2019 shall consist of four members, whereof one shall be the chairman of the Board of Directors. The chairman of the Board of Directors shall not be the chairman in the nomination committee. The other three members shall be composed of members appointed by the three largest shareholders in terms of voting rights as of 31 August.
At the 2019 Annual General Meeting, Isofol Medical’s Nomination Committee consists of:
● Lars Lind, appointed by Biofol AB
● Malin Björkmo, appointed by Handelsbanken Fonder
● Bo Lundgren, appointed by Swedbank Robur Fonder
● Ulf Jungnelius, chairman at Isofol Medical AB (publ)
The nomination committee meets as needed and at least once a year.
The nomination committee prepares proposals for the AGM concerning the election of and remuneration to, the chairman of the Board, Board members and external auditors, the latter having been proposed by the audit committee.
The Nomination Committee’s proposals will be presented in the Notice to the annual general meeting 2019 and on Isofol’s web site, isofolmedical.com
Shareholders wishing to submit a proposal to Isofol’s Nomination Committee 2019 may contact the Nomination Committee by e-mail firstname.lastname@example.org or by the address:
Isofol Medical AB (publ) Att. Valberedningen Arvid Wallgrens Backe 20 413 46 Göteborg Sweden